Log in to save to my catalogue

Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leuk...

Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leuk...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1539264403

Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation

About this item

Full title

Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2014-06, Vol.5 (1), p.4177, Article 4177

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Loss-of-function mutations of
EZH2
, a catalytic component of polycomb repressive complex 2 (PRC2), are observed in ~\n10% of patients with myelodysplastic syndrome (MDS), but are rare in acute myeloid leukaemia (AML). Recent studies have shown that
EZH2
mutations are often associated with
RUNX1
mutations in MDS patients, although...

Alternative Titles

Full title

Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1539264403

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1539264403

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/ncomms5177

How to access this item